Viewing Study NCT05361434


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-27 @ 6:01 AM
Study NCT ID: NCT05361434
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-03
First Post: 2022-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults
Sponsor: Ipsen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module